Klinik und Poliklinik für Neurologie

Publikationen 2001

Abele M, Bürk K, Laccone F, Dichgans J, Klockgether T. Restless legs syndrome in spinocerebellar ataxia types 1, 2, and 3. J Neurol. 2001;248(4):311-4.

Bürk K, Bösch S, Globas C, Zühlke C, Daum I, Klockgether T, Dichgans J. Executive dysfunction in spinocerebellar ataxia type 1. Eur Neurol. 2001;46(1):43-8.

Bürk K, Bösch S, Müller CA, Melms A, Zühlke C, Stern M, Besenthal I, Skalej M, Ruck P, Ferber S, Klockgether T, Dichgans J. Sporadic cerebellar ataxia associated with gluten sensitivity. Brain. 2001;124(Pt 5):1013-9.

Clemen CS, Herr C, Lie AA, Noegel AA, Schröder R. Annexin VII: an astroglial protein exhibiting a Ca2+-dependent subcellular distribution. Neuroreport. 2001;12(6):1139-44.

Evert BO, Vogt IR, Kindermann C, Ozimek L, de Vos RA, Brunt ER, Schmitt I, Klockgether T, Wüllner U. Inflammatory genes are upregulated in expanded ataxin-3-expressing cell lines and spinocerebellar ataxia type 3 brains. J Neurosci. 2001;21(15):5389-96.

Fischer D, Wüllner U, Klockgether T, Schröder R, Wilhelm K. Cervical spondylotic myopathy and Kennedy syndrome mimicking amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2001;71(3):414.

Grothe C, Urbach H, Bös M, Ko Y, Schröder R. [Cerebellar syndrome, exophthalmos and secondary hypogonadism in Erdheim-Chester disease]. Nervenarzt. 2001;72(6):449-52.

Haase CG, Schmidt S. Detection of brain-specific autoantibodies to myelin oligodendrocyte glycoprotein, S100beta and myelin basic protein in patients with Devic's neuromyelitis optica. Neurosci Lett. 2001;307(2):131-3.

Hagendorff A, Kölsch C, Dettmers C, Hartmann A, Pfeiffer D, Lüderitz B. [Is brain blood supply affected by changes in cardiac volume? Measurements of brain blood supply in healthy subjects during volume overload and in patients with artificial pacemaker by changing the pacing rate]. Z Kardiol. 2001;90(1):35-42.

Heneka MT, Feinstein DL. Expression and function of inducible nitric oxide synthase in neurons. J Neuroimmunol. 2001;114(1-2):8-18.

Heneka MT, Landreth GE, Feinstein DL. Role for peroxisome proliferator-activated receptor-gamma in Alzheimer's disease. Ann Neurol. 2001;49(2):276.

Heneka MT, Sharp A, Murphy P, Lyons JA, Dumitrescu L, Feinstein DL. The heat shock response reduces myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in mice. J Neurochem. 2001;77(2):568-79.

Heneka MT, Wiesinger H, Dumitrescu-Ozimek L, Riederer P, Feinstein DL, Klockgether T. Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide synthase in Alzheimer disease. J Neuropathol Exp Neurol. 2001;60(9):906-16.

Herr C, Smyth N, Ullrich S, Yun F, Sasse P, Hescheler J, Fleischmann B, Lasek K, Brixius K, Schwinger RH, Fässler R, Schröder R, Noegel AA. Loss of annexin A7 leads to alterations in frequency-induced shortening of isolated murine cardiomyocytes. Mol Cell Biol. 2001;21(13):4119-28.

Jouvenceau A, Eunson LH, Spauschus A, Ramesh V, Zuberi SM, Kullmann DM, Hanna MG. Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet. 2001;358(9284):801-7.

Jung G, Brandl M, Eisner W, Fraunberger P, Reifenberger G, Schlegel U, Wiestler OD, Reulen HJ, Wilmanns W. Local immunotherapy of glioma patients with a combination of 2 bispecific antibody fragments and resting autologous lymphocytes: evidence for in situ t-cell activation and therapeutic efficacy. Int J Cancer. 2001;91(2):225-30.

Köster J, Schlosser T, Pohl C, Lentz C, Lohmaier S, Veltmann C, Kuntz-Hehner S, Omran H, Lüderitz B, Becher H, Tiemann K. Blood flow assessment by ultrasound-induced destruction of echocontrast agents using harmonic power Doppler imaging: which parameters determine contrast replenishment curves? Echocardiography. 2001;18:1-8.

Korfel A, Finke J, Schmidt-Wolf I, Thiel E. 5. Report on workshop: Primary CNS lymphoma. Ann Hematol. 2001;80 Suppl 3:B20-3.

Kornblum C, Broicher R, Walther E, Seibel P, Reichmann H, Klockgether T, Herberhold C, Schröder R. Cricopharyngeal achalasia is a common cause of dysphagia in patients with mtDNA deletions. Neurology. 2001;56(10):1409-12.

Kraus JA, de Millas W, Sörensen N, Herbold C, Schichor C, Tonn JC, Wiestler OD, von Deimling A, Pietsch T. Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1. Acta Neuropathol (Berl). 2001;102(1):69-74.

Kraus JA, Lamszus K, Glesmann N, Beck M, Wolter M, Sabel M, Krex D, Klockgether T, Reifenberger G, Schlegel U. Molecular genetic alterations in glioblastomas with oligodendroglial component. Acta Neuropathol (Berl). 2001;101(4):311-20.

Kraus JA, Wenghoefer M, Glesmann N, Mohr S, Beck M, Schmidt MC, Schröder R, Berweiler U, Roggendorf W, Diete S, Dietzmann K, Heuser K, Müller B, Fimmers R, von Deimling A, Schlegel U. TP53 gene mutations, nuclear p53 accumulation, expression of Waf/p21, Bcl-2, and CD95 (APO-1/Fas) proteins are not prognostic factors in de novo glioblastoma multiforme. J Neurooncol. 2001;52(3):263-72.

Kuntz-Hehner S, Goenechea J, Pohl C, Schlosser T, Veltmann C, Lentz C, Lohmaier S, Ehlgen A, Omran H, Becher H, Tiemann K. Continuous-infusion contrast-enhanced US: in vitro studies of infusion techniques with different contrast agents. Radiology. 2001;220(3):647-54.

Landreth GE, Heneka MT. Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer's disease. Neurobiol Aging. 2001;22(6):937-44.

Lentini S, Rao ML, Schröder R, Lüderitz B, Bauriedel G. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects]. Dtsch Med Wochenschr. 2001;126(49):1396-400.

Möller HJ, Hartmann A, Kessler C, Rainer M, Brown T, Gamand S, Lehert P. Naftidrofuryl in the treatment of vascular dementia. Eur Arch Psychiatry Clin Neurosci. 2001;251(6):247-54.

Müller T, Schröder R, Zierz S. GCG repeats and phenotype in oculopharyngeal muscular dystrophy. Muscle Nerve. 2001;24(1):120-2.

Paus S, Pötzsch B, Risse JH, Klockgether T, Wüllner U. Chorea and antiphospholipid antibodies: treatment with methotrexate. Neurology. 2001;56(1):137-8.

Pels H, Glasmacher A, Schmidt-Wolf IGH, Schlegel U. Therapy of primary CNS lymphoma. Akt Neurol. 2001;28(4):189-94.

Pohl C, Block W, Karitzky J, Träber F, Schmidt S, Grothe C, Lamerichs R, Schild H, Klockgether T. Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis. Arch Neurol. 2001;58(5):729-35.

Pohl C, Block W, Träber F, Schmidt S, Pels H, Grothe C, Schild HH, Klockgether T. Proton magnetic resonance spectroscopy and transcranial magnetic stimulation for the detection of upper motor neuron degeneration in ALS patients. J Neurol Sci. 2001;190(1-2):21-7.

Schlegel U. The DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med. 2001;344(9):686-7; author reply 687-8.

Schlegel U, Pels H, Glasmacher A, Kleinschmidt R, Schmidt-Wolf I, Helmstaedter C, Fliessbach K, Deckert M, Van Roost D, Fimmers R, Bode U, Klockgether T. Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: a pilot study. J Neurol Neurosurg Psychiatry. 2001;71(1):118-22.

Schlosser T, Pohl C, Veltmann C, Lohmaier S, Goenechea J, Ehlgen A, Köster J, Bimmel D, Kuntz-Hehner S, Becher H, Tiemann K. Feasibility of the flash-replenishment concept in renal tissue: which parameters affect the assessment of the contrast replenishment? Ultrasound Med Biol. 2001;27(7):937-44.

Schmidt S, Haase CG, Bezman L, Moser H, Schmidt M, Köhler W, Linington C, Klockgether T. Serum autoantibody responses to myelin oligodendrocyte glycoprotein and myelin basic protein in X-linked adrenoleukodystrophy and multiple sclerosis. J Neuroimmunol. 2001;119(1):88-94.

Schmidt S, Träber F, Block W, Keller E, Pohl C, von Oertzen J, Schild H, Schlegel U, Klockgether T. Phenotype assignment in symptomatic female carriers of X-linked adrenoleukodystrophy. J Neurol. 2001;248(1):36-44.

Schmidt S, Wessels L, Augustin A, Klockgether T. Patients with Multiple Sclerosis and concomitant uveitis/periphlebitis retinae are not distinct from those without intraocular inflammation. J Neurol Sci. 2001;187(1-2):49-53.

Schröder R, Reimann J, Iakovenko A, Mues A, Bönnemann CG, Matten J, Gautel M. Early and selective disappearance of telethonin protein from the sarcomere in neurogenic atrophy. J Muscle Res Cell Motil. 2001;22(3):259-64.

Schwarz CS, Evert BO, Seyfried J, Schaupp M, Kunz WS, Vielhaber S, Klockgether T, Wüllner U. Overexpression of bcl-2 results in reduction of cytochrome c content and inhibition of complex I activity. Biochem Biophys Res Commun. 2001;280(4):1021-7.

Tiemann K, Veltmann C, Ghanem A, Lohmaier S, Bruce M, Kuntz-Hehner S, Pohl C, Ehlgen A, Schlosser T, Omran H, Becher H. The impact of emission power on the destruction of echo contrast agents and on the origin of tissue harmonic signals using power pulse-inversion imaging. Ultrasound Med Biol. 2001;27(11):1525-33.

Urbach H, Paus S, Tschampa HJ, Keller E, Schild HH. [Creutzfeldt-Jakob disease: value of MRI]. Rofo. 2001;173(6):509-14.

Van Roost D, Hartmann A, Quade G. Changes of cerebral blood flow following dexamethasone treatment in brain tumour patients. A Xe/CT study. Acta Neurochir (Wien). 2001;143(1):37-43; discussion 43-4.

Vielhaber S, Schröder R, Winkler K, Weis S, Sailer M, Feistner H, Heinze HJ, Schröder JM, Kunz WS. Defective mitochondrial oxidative phosphorylation in myopathies with tubular aggregates originating from sarcoplasmic reticulum. J Neuropathol Exp Neurol. 2001;60(11):1032-40.

Voit T, Kutz P, Leube B, Neuen-Jacob E, Schröder JM, Cavallotti D, Vaccario ML, Schaper J, Broich P, Cohn R, Baethmann M, Göhlich-Ratmann G, Scoppetta C, Herrmann R. Autosomal dominant distal myopathy: further evidence of a chromosome 14 locus. Neuromuscul Disord. 2001;11(1):11-9.